ANGO - AngioDynamics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 5/31/2018 5/31/2017 5/31/2016 5/31/2015
Total Revenue 344,285 349,643 351,474 352,392
Cost of Revenue 167,410 171,637 179,574 180,738
Gross Profit 176,875 178,006 171,900 171,654
Operating Expenses
Research Development 25,459 24,869 25,053 26,594
Selling General and Administrative 108,541 109,425 114,326 112,382
Non Recurring - - - -
Others - - - -
Total Operating Expenses 318,045 323,227 336,917 337,680
Operating Income or Loss 26,240 26,416 14,557 14,712
Income from Continuing Operations
Total Other Income/Expenses Net -18,775 -16,569 -17,810 -22,843
Earnings Before Interest and Taxes 26,240 26,416 14,557 14,712
Interest Expense -3,062 -2,839 -3,385 -3,193
Income Before Tax 7,465 9,847 -3,253 -8,131
Income Tax Expense -8,870 4,839 40,337 -4,743
Minority Interest - - - -
Net Income From Continuing Ops 16,335 5,008 -43,590 -3,388
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income 16,335 5,008 -43,590 -3,388
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares 16,335 5,008 -43,590 -3,388